Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Healthtrust
Cantor Fitzgerald
Baxter
Johnson and Johnson
McKinsey
Fuji
Boehringer Ingelheim
Daiichi Sankyo

Generated: January 19, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022408

« Back to Dashboard

NDA 022408 describes NATROBA, which is a drug marketed by Parapro Llc and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the NATROBA profile page.

The generic ingredient in NATROBA is spinosad. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the spinosad profile page.
Summary for 022408
Tradename:NATROBA
Applicant:Parapro Llc
Ingredient:spinosad
Patents:3
Formulation / Manufacturing:see details
Generic Entry Opportunity Date for 022408
Generic Entry Date for 022408*:
Constraining patent/regulatory exclusivity:
Dosage:
SUSPENSION;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for NDA: 022408
Suppliers and Packaging for NDA: 022408
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NATROBA spinosad SUSPENSION;TOPICAL 022408 NDA Allegis Pharmaceuticals, LLC 28595-570 28595-570-04 1 BOTTLE, PLASTIC in 1 CARTON (28595-570-04) > 120 mL in 1 BOTTLE, PLASTIC
NATROBA spinosad SUSPENSION;TOPICAL 022408 NDA ParaPRO LLC 52246-929 52246-929-04 1 BOTTLE, PLASTIC in 1 CARTON (52246-929-04) > 120 mL in 1 BOTTLE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;TOPICALStrength0.9%
Approval Date:Jan 18, 2011TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jul 25, 2023Product Flag?YSubstance Flag?Delist Request?
Patented Use:NATROBA TOPICAL SUSPENSION IS A PEDICULICIDE INDICATED FOR THE TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS SIX (6) MONTHS OF AGE AND OLDER.
Patent:➤ Try a Free TrialPatent Expiration:Jun 22, 2019Product Flag?YSubstance Flag?Delist Request?
Patented Use:TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER
Patent:➤ Try a Free TrialPatent Expiration:Jul 2, 2021Product Flag?YSubstance Flag?Delist Request?
Patented Use:TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Julphar
Dow
Farmers Insurance
Express Scripts
Accenture
Cipla
US Army
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.